Stryker said the device, called the Trevo XP ProVue Retriever, is intended to restore blood flow or remove blood clots in a blood vessel in the brain during an acute ischemic stroke. The company has discovered that there’s a risk the core wire may break or separate during use, which could cause the device to remain inside patients’ blood vessels or tissues. This may lead to bleeding, disability or death.
The company said it has notified all of its customers and asked them to return the devices.
Read the full news release here.
More articles on supply chain:
CDC seeks to create centralized reporting system for COVID-19 test results
Abbott sues former exec, claims he shared trade secrets
FDA warns of potential for false positives in coronavirus antigen tests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
